2167 related articles for article (PubMed ID: 11396322)
21. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
22. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].
Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D
Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
25. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
26. Renal graft survival in children with early acute rejection.
Muñoz R; Romero B; Medeiros M; Zaragoza L
Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
[TBL] [Abstract][Full Text] [Related]
27. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
[TBL] [Abstract][Full Text] [Related]
28. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
Medina-Pestana JO; Felipe CR; Park SI; Machado PG; Garcia R; Spinelli G; Silva LA; Santos CF; Tedesco-Silva H
Transplant Proc; 2004 Mar; 36(2 Suppl):74S-79S. PubMed ID: 15041311
[TBL] [Abstract][Full Text] [Related]
29. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
30. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
31. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
32. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
[TBL] [Abstract][Full Text] [Related]
33. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
34. Outcome of pediatric cadaveric renal transplantation: a 10 year study.
Johnson RW; Webb NJ; Lewis MA; Postlethwaite RJ; Dyer PA; Connolly JK
Kidney Int Suppl; 1996 Jan; 53():S72-6. PubMed ID: 8770995
[TBL] [Abstract][Full Text] [Related]
35. [Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience].
Nagahama K; Yamamoto S; Yoshida H; Nakamura E; Ito N; Kinoshita H; Kamoto T; Okuno H; Ogawa O
Hinyokika Kiyo; 2004 Sep; 50(9):605-10. PubMed ID: 15518124
[TBL] [Abstract][Full Text] [Related]
36. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive regimens and their effects on renal allograft outcome.
Katznelson S; Cecka JM
Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
[TBL] [Abstract][Full Text] [Related]
38. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
Garrido IP; Crespo-Leiro MG; Paniagua MJ; Muñiz J; Vázquez-Rey E; Pérez-Fernández R; García-Lara J; Cuenca-Castillo JJ; Castro-Beiras A
J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
[TBL] [Abstract][Full Text] [Related]
39. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
[TBL] [Abstract][Full Text] [Related]
40. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
